Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Form 8.3 - Surface Transforms PLC

30 Mar 2026 18:33

RNS Number : 7058Y
Asif Justin Zaman
30 March 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Asif Zaman and close relatives

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Surface Transforms Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

27/03/26

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which

 

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

23,798,961

1.83

0

0

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

TOTAL:

23,798,961

1.83

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

None

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

None

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

None

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

None

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

None

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

29 March 2026

Contact name:

Asif Zaman

Telephone number*:

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETJMMRTMTTJBTF
Date   Source Headline
27th Feb 20187:00 amRNSHalf-year Report
4th Jan 20187:00 amRNSGrant of Options
2nd Jan 201812:05 pmRNSAppointment of new Financial Director
28th Nov 20172:18 pmRNSResult of AGM
20th Nov 20177:00 amRNSTrading and Operations Update
20th Sep 201712:07 pmRNSHolding(s) in Company
20th Sep 20179:34 amRNSGrant of Options
19th Sep 20177:00 amRNSPreliminary Results and Notice of AGM
9th Aug 20173:47 pmRNSResult of Open Offer Excess
27th Jul 20174:29 pmRNSHolding(s) in Company
26th Jul 201711:21 amRNSOpen Offer Excess
25th Jul 201711:51 amRNSResult of General Meeting
25th Jul 201711:13 amRNSResult of Open Offer
6th Jul 20173:00 pmRNSDirector/PDMR Shareholding
6th Jul 201712:09 pmRNSResult of Placing
6th Jul 201711:45 amRNSResult of Placing
6th Jul 20177:00 amRNSProposed Placing and Open Offer
20th Jun 20177:01 amRNSInvestors Open Day
20th Jun 20177:00 amRNSOperations, Customer and Pre Close Trading Update
18th Apr 20174:56 pmRNSExercise of Options
16th Mar 20178:20 amRNSExercise of Options
13th Feb 20177:00 amRNSHalf Yearly Results
2nd Feb 20177:00 amRNSTrading Update
6th Jan 20173:49 pmRNSChange of Registered Office
8th Dec 20167:00 amRNSTrading Update
29th Nov 20161:14 pmRNSResult of AGM
18th Oct 20164:14 pmRNSHolding(s) in Company
10th Oct 20167:00 amRNSPreliminary Results and Trading Statement
3rd Oct 20167:00 amRNSExercise of Options
5th Sep 20167:00 amRNSNotice of Results
2nd Aug 201610:42 amRNSHolding(s) in Company
11th Jul 20167:00 amRNSPre-Production Technology Development Agreement
15th Jun 20167:00 amRNSTrading, Premises and Operating Update
14th Apr 20165:18 pmRNSDirector Dealing
14th Apr 20162:33 pmRNSDirector Dealing & Director Interests in Company
14th Apr 20167:00 amRNSResult of Open Offer and Total Voting Rights
11th Apr 20167:00 amRNSDirector Dealing
6th Apr 201612:18 pmRNSHolding(s) in Company
4th Apr 20162:01 pmRNSResult of General Meeting
29th Mar 20167:00 amRNSDirector Dealing
18th Mar 20167:00 amRNSPlacing, Open Offer & Notice of General Meeting
18th Feb 20167:00 amRNSGrant Income of £600,000 and New Factory
3rd Feb 20167:00 amRNSHalf Yearly Results
7th Dec 20157:00 amRNSTrading Update
24th Nov 20154:00 pmRNSResult of AGM
12th Nov 201512:50 pmRNSReplacement: Exercise of Options
12th Nov 20157:00 amRNSExercise of Options
20th Oct 20158:51 amRNSHolding(s) in Company
8th Oct 201510:36 amRNSHolding(s) in Company
2nd Oct 201512:00 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.